Connelly Robert
SEC insider (Form 3/4/5 filer). CIK 0001796436. CEO, President and Director at Elicio Therapeutics, Inc. (ELTX). 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 16, 2026. Located in BOSTON, MA.
Companies Connelly Robert has filed insider reports for
- Elicio Therapeutics, Inc. (ELTX): Director, Officer, CEO, President and Director
Connelly Robert
CIK: 0001796436
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Elicio Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 16, 2026ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
186.9K shares- - Feb 2, 2026ELTX
Elicio Therapeutics, Inc.
AwardDirect73.6K shares- - Feb 3, 2025ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
121.6K shares- - Sep 30, 2024ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
91.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2026 | ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 186,944 | - | - | Direct |
| Feb 2, 2026 | ELTX Elicio Therapeutics, Inc. | Award | 73,600 | - | $0 | Direct |
| Feb 3, 2025 | ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 121,600 | - | - | Direct |
| Sep 30, 2024 | ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 91,600 | - | - | Direct |
1-4 of 4 transactions